These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3878417)

  • 21. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
    Ishikawa M; Kumashiro M; Yamazaki Y; Atoda H; Morita T
    J Biochem; 2009 Jan; 145(1):123-8. PubMed ID: 18977769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interactions of blood coagulation factors (author's transl)].
    Cierniewski CS; Krajewski T
    Postepy Biochem; 1981; 27(1):81-105. PubMed ID: 6792614
    [No Abstract]   [Full Text] [Related]  

  • 24. Basic mechanisms in blood coagulation.
    Davie EW; Fujikawa K
    Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463
    [No Abstract]   [Full Text] [Related]  

  • 25. The activation of factor IX by the tissue factor pathway.
    Rapaport SI
    Prog Clin Biol Res; 1981; 72():57-76. PubMed ID: 7335650
    [No Abstract]   [Full Text] [Related]  

  • 26. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
    [No Abstract]   [Full Text] [Related]  

  • 27. Activation pathways of the coagulation system in normal haemostasis.
    Osterud B
    Scand J Haematol; 1984 Apr; 32(4):337-45. PubMed ID: 6372076
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemostasis in surgical procedures.
    Quick AJ
    Surg Gynecol Obstet; 1969 Mar; 128(3):523-32. PubMed ID: 4180878
    [No Abstract]   [Full Text] [Related]  

  • 29. Activation of clotting factors in prothrombin complex concentrates as demonstrated by clotting assays for factors IXa and Xa.
    Elödi S; Váradi K
    Thromb Res; 1978 May; 12(5):797-807. PubMed ID: 675589
    [No Abstract]   [Full Text] [Related]  

  • 30. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel inhibitor of factor X activation from the salivary glands of the bed bug Cimex lectularius.
    Valenzuela JG; Guimaraes JA; Ribeiro JM
    Exp Parasitol; 1996 Jul; 83(2):184-90. PubMed ID: 8682187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood coagulation.
    Jackson CM; Nemerson Y
    Annu Rev Biochem; 1980; 49():765-811. PubMed ID: 6996572
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular interactions of the intrinsic activation complex of coagulation: binding of native and activated human factors IX and X to defined phospholipid vesicles.
    Burri BJ; Edgington TS; Fair DS
    Biochim Biophys Acta; 1987 Feb; 923(2):176-86. PubMed ID: 3493031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [General mechanisms of coagulation and their physiological inhibition. I. General mechanisms of blood coagulation].
    Guillin MC; Bezeaud A
    Pathol Biol (Paris); 1985 Oct; 33(8):847-57. PubMed ID: 3903625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Half-life time and control frequency of vitamin K-dependent Coagulation factors. Theoretical considerations on the place of factor VII in the control of oral anticoagulation therapy.
    van Dam-Mieras MC; Hemker HC
    Haemostasis; 1983; 13(3):201-8. PubMed ID: 6350124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin therapy in the case of acute liver cirrhosis.
    Fischer M; Gauss P; Korp W; Nobis H; Schnack B; Weissmann A
    Scand J Gastroenterol Suppl; 1973; 19():135-8. PubMed ID: 4515636
    [No Abstract]   [Full Text] [Related]  

  • 37. The functional significance of vitamin K action.
    Nutr Rev; 1976 Jun; 34(6):182-3. PubMed ID: 781557
    [No Abstract]   [Full Text] [Related]  

  • 38. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Initiation of blood coagulation].
    Saito H
    Rinsho Byori; 1985 Sep; 33(9):960-5. PubMed ID: 3878416
    [No Abstract]   [Full Text] [Related]  

  • 39. The normal coagulation mechanism.
    Bennett B; Ratnoff OD
    Med Clin North Am; 1972 Jan; 56(1):95-104. PubMed ID: 4550195
    [No Abstract]   [Full Text] [Related]  

  • 40. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa.
    Scandura JM; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8903-13. PubMed ID: 8688426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.